Cargando…
Combined adjuvants of poly(I:C) plus LAG‐3‐Ig improve antitumor effects of tumor‐specific T cells, preventing their exhaustion
Therapeutic cancer vaccines are designed to treat cancer by boosting the endogenous immune system to fight against the cancer. In the development of clinically effective cancer vaccines, one of the most practical objectives is to identify adjuvants that are capable of optimizing the vaccine effects....
Autores principales: | Kano, Yosuke, Iguchi, Takahiro, Matsui, Hiroto, Adachi, Keishi, Sakoda, Yukimi, Miyakawa, Tomoya, Doi, Shun, Hazama, Shoichi, Nagano, Hiroaki, Ueyama, Yoshiya, Tamada, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832865/ https://www.ncbi.nlm.nih.gov/pubmed/27079438 http://dx.doi.org/10.1111/cas.12861 |
Ejemplares similares
-
Improved survival of chimeric antigen receptor‐engineered T (CAR‐T) and tumor‐specific T cells caused by anti‐programmed cell death protein 1 single‐chain variable fragment‐producing CAR‐T cells
por: Nakajima, Masao, et al.
Publicado: (2019) -
Therapeutic effects of anti‐GM2 CAR‐T cells expressing IL‐7 and CCL19 for GM2‐positive solid cancer in xenograft model
por: Sasaki, Takahiro, et al.
Publicado: (2023) -
Anti‐tumor efficacy of human anti‐c‐met CAR‐T cells against papillary renal cell carcinoma in an orthotopic model
por: Mori, Jun‐ich, et al.
Publicado: (2021) -
Identification of a Promiscuous Epitope Peptide Derived From HSP70
por: Matsui, Hiroto, et al.
Publicado: (2019) -
Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy
por: Hazama, Shoichi, et al.
Publicado: (2018)